Epidural Dexmedetomidine vs Nalbuphine for Labor Analgesia
Epidural Anesthesia, Labor Pain
About this trial
This is an interventional treatment trial for Epidural Anesthesia focused on measuring Dexmedetomidine, Nalbuphine
Eligibility Criteria
Inclusion Criteria:
All the parturients should :
- Be between 21 - 40 years old
- ASA classification I- II
- Para 1-2
- Requesting analgesia
- Have a normal birth canal
- Be at the beginning of active phase of labor i.e. cervical dilatation of 4 cm with regular uterine contractions.
- The fetus should be a single full-term fetus (37- 42 weeks of gestation) with normal head position, normal development.
Exclusion Criteria:
Parturients
- Younger than 21 and older than 40 years old
- With contraindication of regional anesthesia
- With pre-existing neurological disease
- With history of allergy to the study drugs
- With cephalopelvic disproportion, fetal distress, amniotic fluid infection, placental insufficiency or scarred uterus
Sites / Locations
- Ain Shams University
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Group A (Dexmedetomidine group)
Group B (Nalbuphine group)
a bolus dose of 11ml of 0.25% bupivacaine + 0.5μg/ml preservative free dexmedetomidine (1ml volume) will be injected via the epidural catheter. For top up 5 ml of 0.25% bupivacaine + 0.5μg/ml dexmedetomidine (1ml volume) will be given when VAS score becomes 4 or more.
a bolus dose of 11ml of 0.25% bupivacaine + 10mg preservative free nalbuphine (1ml volume) will be injected via the epidural catheter. For top up 5 ml of 0.25% bupivacaine + 2mg nalbuphine (1ml volume) will be given when VAS score becomes 4 or more.